Literature DB >> 27449627

Reversible NaCl-induced aggregation of a monoclonal antibody at low pH: Characterization of aggregates and factors affecting aggregation.

Fabian Bickel1, Eva Maria Herold2, Alba Signes2, Stefan Romeijn3, Wim Jiskoot3, Hans Kiefer2.   

Abstract

We investigated the influence of pH and sodium chloride concentration on aggregation kinetics of a monoclonal antibody. Aggregation was induced by sodium chloride addition at low pH. Protein conformation before and after salt addition was determined as well as the reversibility of aggregation. Aggregation was monitored at pH values between 2 and 7 with NaCl up to 1.5M by turbidity measurement and size-exclusion chromatography. Particle size distribution was assessed by using size-exclusion chromatography as well as nanoparticle tracking analysis and flow imaging microscopy. Structural changes were monitored by circular dichroism, Fourier transform infrared and fluorescence spectroscopy. Thermal stability was measured by differential scanning fluorimetry. Aggregation propensity was maximal at low pH and high ionic strength. While thermal stability decreased with pH, the secondary structure remained unchanged down to pH 3.5 and up to 1.5M NaCl. Precipitated protein could be largely reverted to monomers by dilution into salt-free buffer. The re-solubilized antibody was indistinguishable in structure, solubility and monodispersity from the unstressed protein. Also, binding to Protein A was steady. Aggregation could be reduced in the presence of trehalose. The results suggest a reversible aggregation mechanism characterized by a limited change in tertiary structure at low pH and a subsequent loss of colloidal stability resulting from electrostatic repulsion once salt is added to the sample. The experimental setup is robust and allows high-throughput quantification of the effect of additives on aggregation kinetics.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acidic conditions; Aggregate; Downstream processing; IgG; MAb; Reversibility; Salt

Mesh:

Substances:

Year:  2016        PMID: 27449627     DOI: 10.1016/j.ejpb.2016.07.020

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  5 in total

1.  Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification.

Authors:  Weixin Jin; Zizhuo Xing; Yuanli Song; Chao Huang; Xuankuo Xu; Sanchayita Ghose; Zheng Jian Li
Journal:  MAbs       Date:  2019-09-02       Impact factor: 5.857

Review 2.  Recombinant antibodies aggregation and overcoming strategies in CHO cells.

Authors:  Tingting Xu; Jihong Zhang; Tianyun Wang; Xiaoyin Wang
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-24       Impact factor: 4.813

Review 3.  Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins.

Authors:  Michael R Turner; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2018-01-11       Impact factor: 3.534

4.  Exploring synthetic biology for the development of a sensor cell line for automated bioprocess control.

Authors:  Nikolas Zeh; Melina Bräuer; Nadja Raab; René Handrick; Kerstin Otte
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.996

5.  Membrane Adsorber for the Fast Purification of a Monoclonal Antibody Using Protein A Chromatography.

Authors:  Chantal Brämer; Lisa Tünnermann; Alina Gonzalez Salcedo; Oscar-Werner Reif; Dörte Solle; Thomas Scheper; Sascha Beutel
Journal:  Membranes (Basel)       Date:  2019-11-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.